Skip to main content
Premium Trial:

Request an Annual Quote

Roche and GE Healthcare Partner on Alzheimer s Drug-Response Study

NEW YORK, July 11 (GenomeWeb News) - Roche and GE Healthcare will collaborate on a personalized approach to treating Alzheimer's disease, the companies said today.

 

The companies will partner on controlled clinical trials in which patients taking a Roche anti-amyloid drug candidate for Alzheimer's disease will be monitored for drug response using GE's positron emission tomography diagnostic imaging agent.

 

This PET-based technology is able to monitor levels of beta-amyloid, a form of brain plaque believed to cause memory loss in Alzheimer's disease patients. The companies said that this plaque could previously only be confirmed during autopsy.

 

Roche and GE Healthcare said they will independently analyze patient data and share information to validate the efficacy of the therapeutic product and the PET-based diagnostic tool.

 

This data will enable Roche and GE to submit "necessary and comprehensive data to regulatory authorities for approvals," the companies said.

 

Financial terms were not disclosed.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.